Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Tolerability of Eribulin Plus Lapatinib in Patients With Metastatic Breast Cancer (E-VITA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01534455
Recruitment Status : Terminated (very slow patient recruitment and concerns about the actuality of the study design)
First Posted : February 16, 2012
Last Update Posted : February 10, 2016
Sponsor:
Information provided by (Responsible Party):
German Breast Group

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : March 2015
Actual Study Completion Date : March 2015